XML 15 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flow From Operating Activities:    
Net income $ 8,547 $ 418,901
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gain on sale or write down of assets (156) (16,580)
Gain on foreign currency transactions (993) (19,437)
Loss on early extinguishment of debt 1,710 2,805
Depreciation and amortization 10,518 9,409
Provision (recovery) of bad debts 875 (3,126)
Equity in income from unconsolidated joint ventures (2,946) (471,385)
Distribution of income from unconsolidated joint ventures 0 3,700
Changes in assets and liabilities, net of dispositions:    
Other assets (11,336) (4,925)
Related party receivables (4,369) (6,630)
Accrued interest (1,872) (4,652)
Accounts payable and other liabilities 7,868 85,046
Net cash provided by (used in) operating activities 7,846 (6,874)
Cash Flow From Investing Activities:    
Collection of notes receivable 394 2,726
Originations and advances on notes receivable (6,500) (2,118)
Purchase of short-term investments (89,566) (99,350)
Redemption of short-term investments 75,168 40,250
Development and renovation of real estate (9,876) (11,834)
Deferred leasing costs (290) (1,163)
Proceeds from sale of assets 188 44,591
Distribution from unconsolidated joint venture 20,916 181,748
Net cash (used in) provided by investing activities (9,566) 154,850
Cash Flow From Financing Activities:    
Payments on mortgages, other notes and bonds payable (136,809) (70,170)
Debt extinguishment costs (435) (1,354)
Deferred financing costs (16) 0
Net cash used in financing activities (137,260) (71,524)
Net (decrease) increase in cash, cash equivalents and restricted cash (138,980) 76,452
Cash, cash equivalents and restricted cash, beginning of period 222,328 72,734
Cash, cash equivalents and restricted cash, end of period $ 83,348 $ 149,186